ICU丧亲家庭代理决策者的延长哀伤、创伤后应激与抑郁共病轨迹
这项在2家台湾医学中心ICU开展的队列研究纳入303名负责决策的家庭代理决策者,在患者死亡后6、13、18、24个月评估延长哀伤(PG-13的11个哀伤症状条目)、创伤后应激(事件影响量表修订版)和抑郁症状(医院焦虑抑郁量表抑郁亚量表),采用潜变量增长混合模型和联合潜类别分析识别轨迹。延长哀伤、创伤后应激和抑郁症状各识别出3条轨迹:韧性轨迹分别占83.5%、82.5%、66.0%;延长哀伤和创伤后应激的恢复轨迹分别占11.9%、13.5%,抑郁症状的中度轨迹占23.8%提示持续中度痛苦;延长哀伤和抑郁症状的慢性轨迹分别占4.6%、10.2%,创伤后应激另有延迟起病轨迹占4.0%。75.2%的代理决策者三种症状轨迹共现,联合模式为韧性81.5%、恢复14.1%、痛苦4.5%。作者认为哀伤相关心理症状演变复杂异质,部分代理决策者单独或共同经历持续升高的延长哀伤、创伤后应激和抑郁症状,强调早期筛查识别共病心理痛苦轨迹高风险人群的重要性。
要点
- ICU丧亲代理决策者中,4.5%(14/303)呈韧性、恢复、痛苦三症状联合的痛苦轨迹,即持续高痛苦共病。
- 延长哀伤慢性轨迹占4.6%(14/303)、抑郁症状慢性轨迹占10.2%(31/303),创伤后应激延迟起病轨迹占4.0%(12/303)。
- 抑郁症状中度轨迹占23.8%(72/303),提示持续中度痛苦;抑郁症状韧性轨迹仅66.0%(200/303)。
- 75.2%(228/303)的代理决策者三种症状轨迹共现,但多种模式不一致。
- 作者认为应早期筛查,以识别共病心理痛苦轨迹高风险的ICU丧亲代理决策者。
适用人群与场景
- 2018年1月至2020年3月在2家台湾医学中心ICU住院期间死亡患者的家庭代理决策者,负责决策并提供患者死亡后6至24个月数据者。
诊断标准与关键阈值
- 延长哀伤采用PG-13的11个哀伤症状条目评估;创伤后应激采用事件影响量表修订版评估;抑郁症状采用医院焦虑抑郁量表抑郁亚量表评估,评估时点为患者死亡后6、13、18、24个月。
研究设计与关键结果
- 研究类型为队列研究,纳入303名代理决策者,68.3%(207/303)年龄小于56岁,58.4%(177/303)为女性,75.2%(228/303)已婚,与患者关系以配偶29.0%(88/303)或成年子女54.8%(166/303)为主。
- 延长哀伤识别出3条轨迹:韧性83.5%(253/303)、恢复11.9%(36/303)、慢性4.6%(14/303)。
- 创伤后应激识别出3条轨迹:韧性82.5%(250/303)、恢复13.5%(41/303)、延迟起病4.0%(12/303)。
- 抑郁症状识别出3条轨迹:韧性66.0%(200/303)、中度23.8%(72/303,持续中度痛苦)、慢性10.2%(31/303,持续高痛苦)。
- 75.2%(228/303)的代理决策者三种症状轨迹共现,但多种模式不一致。
- 联合轨迹模式:韧性81.5%(247/303),条件概率为延长哀伤0.999、创伤后应激0.999、抑郁症状0.804;恢复14.1%(43/303),条件概率为延长哀伤0.854、创伤后应激0.890、抑郁症状0.588;痛苦4.5%(14/303),条件概率为延长哀伤0.921、创伤后应激0.789、抑郁症状0.980。
证据类型、等级与局限
- 证据类型为队列研究;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,部分ICU丧亲代理决策者单独或共同经历持续升高的延长哀伤、创伤后应激和抑郁症状,强调早期筛查以识别共病心理痛苦轨迹高风险人群的重要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Family surrogates of patients who die in an intensive care unit (ICU) are at risk of cooccurring prolonged grief disorder (PGD), posttraumatic stress disorder (PTSD), and depressive disorder during bereavement, but symptom trajectories are often explored individually.
OBJECTIVES: To simultaneously examine and determine co-occurrence of PGD, PTSD, and depressive symptom trajectories.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study was conducted in ICUs of 2 Taiwanese medical centers from January 2018 to March 2020, with follow-up through July 2022. Participants included surrogates responsible for decision-making who provided data 6 to 24 months after the death of their loved one. Data were analyzed from August to December 2022.
MAIN OUTCOMES AND MEASURES: PGD was assessed with the 11 grief symptom items of the PG-13; PTSD, the Impact of Event Scale-Revised; and depressive symptoms, the depression subscale of the Hospital Anxiety and Depression Scale at 6, 13, 18, and 24 months after the death. Latent growth mixture modeling was conducted to identify distinct trajectories, and joint latent class analysis was used to assess joint patterns of trajectories.
RESULTS: A total of 303 participants were included, with most younger than 56 years (207 participants [68.3%]), female (177 participants [58.4%]), and married (228 participants [75.2%]), and their relationship with the patient was mostly spouse (88 participants [29.0%]) or adult child (166 participants [54.8%]). Three trajectories were identified each for PGD, PTSD, and depressive symptoms. A resilience trajectory was predominant across PGD (253 participants [83.5%]), PTSD (250 participants [82.5%]), and depressive (200 participants [66.0%]) symptoms. Second most common was a recovery trajectory identified for PGD (36 participants [11.9%]) and PTSD (41 participants [13.5%]) symptoms, while for depressive symptoms, a moderate trajectory (72 participants [23.8%]) signified persistent moderate distress. A chronic trajectory characterized by persistently high distress was identified for PGD (14 participants [4.6%]) and depressive (31 participants [10.2%]) symptoms, whereas a unique delayed-onset trajectory (12 participants [4.0%]) was identified for PTSD symptoms. Most family surrogates (228 participants [75.2%]) experienced cooccurring PGD, PTSD, and depressive symptom trajectories, but multiple patterns were discordant. Symptom trajectories cooccurred in joint patterns: resilient (247 participants [81.5%]), recovered (43 participants [14.1%]), and distressed (14 participants [4.5%]). These patterns were characterized by high conditional probabilities for the resilience (PGD, 0.999; PTSD, 0.999; depressive, 0.804), recovery (PGD, 0.854; PTSD, 0.890; depressive, 0.588), and chronic (PGD, 0.921; PTSD, 0.789; depressive, 0.980) symptom trajectories.
CONCLUSIONS AND RELEVANCE: In this cohort study, grief-related psychological symptoms evolved in complex ways during ICU bereavement, as characterized by heterogeneous trajectories. Some ICU bereaved surrogates experienced persistent elevated PGD, PTSD, and depressive symptoms individually or conjointly, underscoring the importance of early screening to identify this population at high risk of comorbid psychological distress trajectories.
参考来源
- Wen FH, Prigerson HG, Chou WC, et al. Comorbid Prolonged Grief, PTSD, and Depression Trajectories for Bereaved Family Surrogates. JAMA Netw Open. 2023. PMID: 37948078. doi:10.1001/jamanetworkopen.2023.42675
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。